1,3,5-Triazido-2,4,6-trinitrobenzene
1,3,5-Triazido-2,4,6-trinitrobenzene
1,3,5-Triazido-2,4,6-trinitrobenzene (TATNB) is a highly energetic chemical compound that belongs to the class of azido compounds. It is known for its explosive properties and is studied for its potential applications in explosives and propellants.
Structure
1,3,5-Triazido-2,4,6-trinitrobenzene is a derivative of benzene where three hydrogen atoms are replaced by azido groups (N_) and three others by nitro groups (NO_). The presence of these functional groups makes the compound highly reactive and sensitive to external stimuli such as heat, shock, and friction.
Synthesis
The synthesis of 1,3,5-Triazido-2,4,6-trinitrobenzene involves the nitration of benzene to form 1,3,5-trinitrobenzene, followed by the substitution of the nitro groups with azido groups. This process requires careful handling due to the sensitivity of the intermediates and the final product.
Properties
1,3,5-Triazido-2,4,6-trinitrobenzene is characterized by its high density and explosive power. It is sensitive to mechanical stimuli and can decompose violently under certain conditions. The compound's stability is a subject of research, as it is crucial for its safe handling and storage.
Decomposition
The decomposition of 1,3,5-Triazido-2,4,6-trinitrobenzene is a highly exothermic process that releases a large amount of gas and energy. This property is exploited in its use as an explosive material. The decomposition can be initiated by heat, shock, or friction.
Applications
Due to its explosive nature, 1,3,5-Triazido-2,4,6-trinitrobenzene is studied for use in military and industrial applications. It is considered for use in detonators, explosive charges, and propellants. However, its sensitivity poses challenges for practical applications.
Safety and Handling
Handling of 1,3,5-Triazido-2,4,6-trinitrobenzene requires strict safety protocols to prevent accidental detonation. Protective equipment and controlled environments are necessary to minimize risks during synthesis, storage, and use.
Related pages
Gallery
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD